Subcutaneous administration is preferred by patients, physicians and healthcare providers, and is associated with a reduction in healthcare costs ... Dec 23
Tuznue is a mAb biosimilar to Roche’s Herceptin (trastuzumab)... Nov 13
Semglee is to be offered in vial and pen presentations... Jun 12
The experimental antibody has neutralized the virus in cell cultures. While that's early in the drug development process, the antibody may help prevent or ... May 05
ONTRUZANT is Samsung Bioepis’ first oncology biosimilar available in the United States ... Apr 16
-Advertisements-